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The gap junction family of proteins is widely expressed in mammalian cells and form intercellular
channels between adjacent cells, as well as hemichannels, for transport of molecules between the
cell and the surrounding environment. In addition, gap junction proteins have recently been impli-
cated as important for the regulation of cell adhesion and migration in a variety of cell types. The
gap junction protein connexin43 (Cx43) regulates B lymphocyte adhesion, BCR- and LFA-1-mediated
activation of the GTPase Rap1, and cytoskeletal rearrangements resulting in changes to cell shape
andmembrane spreading. We demonstrate here that the actin cytoskeleton is important for the dis-
tribution of Cx43 in the B cell plasma membrane and for other cell processes involving the cytoskel-
eton. Using shRNA knockdown of Cx43 in B lymphoma cells we show that Cx43 is also necessary for
chemokine-mediated Rap 1 activation, motility, CXCL12-directed migration, and movement across
an endothelial cell monolayer. These results demonstrate that in addition to its role in B cell spread-
ing, Cx43 is an important regulator of B-cell motility and migration, processes essential for normal
B-cell development and immune responses.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Cell Derived Factor-1 (SDF-1)) [3]. Bone marrow stromal cells pro-The regulation of cellular processes that rely on cytoskeletal
rearrangements, including cell adhesion, spreading, motility, direc-
ted migration and extravasation (transendothelial migration), are
important and essential aspects of B cell development and immune
function. In order to develop into mature B cells, the majority of
immature B cells have to migrate from the bone marrow to the
spleen, where they receive signals that further direct their develop-
ment [1]. Within the spleen, or other secondary lymphoid organs,
there is choreographed migration into different niches which not
only direct further development, but also provide an environment
for interactionswith antigens [1]. The direction of thesemovements
is determined by the interaction between gradients of chemokines
and their receptors located on the cell surfaces of B cells [2].
B cell precursors are retained in the bone marrow due to their
interaction with the chemokine CXCL12 (also known as Stromalduce CXCL12, which signals pro- and pre-B cells to stay in contact
with stromal cells, and may also act by directly stimulating growth
[3]. As B cell precursors begin to express IgM B cell antigen recep-
tors (BCR) on their surface, they down-regulate their responsive-
ness to CXCL12, allowing them to home along a CXCL13 (also
known as B Lymphocyte Chemoattractant Protein (BCP)) gradient
to the spleen [2,3]. In order to complete this long migration, the
developing B cells need to be able to transit into and out of the
blood stream. This is accomplished through the biological process
known as extravasation (transendothelial migration) [4]. When
migrating B cells come in contact with an endothelial cell barrier
that stands between the cells and the ﬁnal destination, they under-
go a well characterized series of events which involve tethering
and rolling along the endothelial cell layer, integrin-mediated ar-
rest, spreading, crawling and ultimately migration between the
endothelial cells [4]. Though these biological processes differ with
respect to their signaling cues, they all share a fundamental
requirement for regulated rearrangements of the cytoskeleton.
The gap junction (GJ) protein connexin43 (Cx43) is expressed in
many cell types, including hematopoetic cells and in B cells, where
it may play important biological roles that are not related to
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bine to form hexameric hemichannels called connexons which can
associate with connexons on adjacent cells to form GJs, allowing
the regulated passage of ions and small molecules (generally less
than 1 kDa) such as Ca++, ATP and cAMP [5]. Along with its role
in cell–cell communication, Cx43 has also been identiﬁed as play-
ing a role in glioma and neural cell motility and migration [8–11].
Knockdown of Cx43 protein expression by in utero transfection of
Cx43 shRNA, or using a neuron-progenitor speciﬁc conditional
knockout, resulted in decreased neuronal migration; however,
the role of the different domains of the Cx43 protein in this process
remains unclear [9–11]. Cx43 has previously been investigated in B
cell extravasation (also called transendothelial cell migration),
where it has been shown that B cells and endothelial cells do form
functional gap junctions [6]. Using an endothelial monolayer
loaded with a cytosolic dye which is GJ permeable, B cells accumu-
lated the dye as they passed through the monolayer; however,
blocking the GJ pore, severely limiting GJ communication, had no
effect on extravasation itself [6].
We have previously shown that Cx43 plays an important role in
the sustained activation of BCR-mediated Rap1 GTPase and spread-
ing, as well as integrin-mediated Rap1 activation, spreading and
adhesion to an endothelial monolayer [12]. Given that Cx43 plays
an important role in neuronal and glial cell migration, and that B
cells express functional GJ proteins, we hypothesized that Cx43
plays a role in B cell motility and migration, possibly by means
other then by its channel function. Using a combination of micros-
copy and loss-of-function assays, we show that the organization of
Cx43 in the membrane is dependent on the F-actin cytoskeleton,
and that it is necessary for B cell motility, CXCL12-mediated
Rap1 activation, directed migration and transendothelial cell
migration (extravasation). These results demonstrate that Cx43 is
an important regulator of B cell migration and raise a number of
interesting questions about the inﬂuence Cx43 may have on B cell
development, immune function, and B cell cancer progression.
2. Materials and methods
2.1. Plasmids, antibodies and inhibitors
Expression vectors encoding cDNA for rat wild type Cx43
(NAP2-Cx43GFP) have been described [8,12,13]. Retroviral vectors
encoding Cx43 shRNA constructs 1 and 2, as well as the corre-
sponding scrambled sequence, have been described [12,14].
Rabbit anti-Cx43, which recognizes an epitope in the C-terminal
domain (aa 363–382; #C6219), mouse anti-b-actin (#A1978) and
rabbit anti-ZO-1 (#HPA001636) were from Sigma–Aldrich (St.
Louis, MO). Rabbit anti-Rap1A/1B was from Cell Signaling Technol-
ogy (Santa Cruz, CA; #23995). Goat anti-rabbit IgG (H + L)
conjugated to horseradish peroxidase (HRP) and goat anti-mouse
IgG (H + L) conjugated to HRP antibodies were purchased from
Bio-Rad (#170-6515 and #170-6516, respectively), Mississauga,
Ontario. Alexa Fluor 488-conjugated goat anti-Rabbit IgG and rho-
damine-coupled phalloidin were from Life Technologies/Invitro-
gen/Molecular Probes. Cytochalasin D was from Enzo Life
Sciences International, Inc. (Plymouth Meeting, PA) and DMSO
was from MP Biomedical, LLC (Solon, OH).
2.2. Cells and tissue culture
The WEHI 231 B lymphoma, the mouse brain endothelioma
bEND.3 and the mouse lymphoid endothelial SVEC4–10 cell lines
were obtained from the American Type Culture Collection (ATCC;
Manassas, VA). Cells were cultured in high glucose (4.5 g/L)
RPMI-1640 (WEHI 231) or DMEM (bEND.3 and SVEC4–10) with
2 mM L-glutamine, 110 mg/L sodium pyruvate, 10% heat-inacti-vated Fetal Bovine Serum (FBS), 50 units/mL of pen/strep. Expres-
sion in WEHI 231 cells of Cx43-EGFP or retroviral vectors encoding
Cx43 shRNA constructs 1 and 2, as well as the corresponding non-
sense sequence was by incubating supernatants of 293-GPG cells
containing the retrovirally packaged plasmids with 5  105 WEHI
231 cells overnight at 37 C [12,15]. EGFP-positive cells were iso-
lated by Flow Cytometry (FACS; UBC Flow http://www.ubcﬂow.ca).
Selection of shRNA transduced WEHI 231 cells was done by drug
selection (1 lg/ml Hygromycin B; Invitrogen Life Technologies).
2.3. Stimulation of B cells and preparation of cell extracts
Cells were washed with PBS, resuspended at 5  106 cells/ml in
modiﬁed HEPES-buffered saline (25 mM sodium HEPES pH 7.4,
125 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM Na2HPO4, 0.5 mM,
1 g/L glucose, 2 mM glutamine, 1 mM sodium pyruvate, 50 lM 2-
ME), and stimulated with 100 nM CXCL12 (R&D systems, Minneap-
olis, MN). Reactions were stopped with 1 ml cold PBS. Cells were
lysed in cold lysis buffer (PBS, 1% Triton-X 100, 1% IGEPAL (Sig-
ma–Aldrich), 50 mM CaCl2) [12,15] containing protease inhibitors
(10 lg/ml leupeptin, 1 lg/ml aprotinin, 1 mM pepstatin A, 1 mM
Na3VO4, 1 mM PMSF). To extract Cx43, cells were lysed in 200 ll
of lysis buffer, sonicated for 10 s, and incubated at 37 C for
30 min before being analyzed by SDS–PAGE [12].
Dephosphorylation of Cx43 was performed as follows. WEHI
231 cells were resuspended to 1  107 cells in 500 ll quinsaline
per timepoint. Cells were stimulated for 0, 5, 10, 15, 30, 60, and
120 min 100 nM CXCL12 at 37 C. Reactions were stopped using
500 ll cold PBS. Cells were centrifuged at 1500 RPM at 4 C for
2 min, supernatants were removed and were lysed as previously
described. Protein concentration of the cell lysates was determined
using a BCA assay (Thermo Scientiﬁc Pierce, Rockford, Illinois). For
each timepoint, lysates were split into two sets containing 30 lg of
protein each, one subjected to dephosphorylation and the other
used as a control. Control lysates were suspended in 1 NEBuffer
(New England BioLabs Inc, Ipswich, Massachusetts). Dephospho-
rylation of the remaining lysates was carried out using 1 NEBuf-
fer and 30 units of Calf Intestinal Alkaline Phosphatase (CIP) (New
England BioLabs Inc) as per manufacturer’s instructions. Lysates
were incubated for 60 min at 37 C and subsequently suspended
in 1 SDS–PAGE as described above.
2.4. Rap1 activation assay
Rap1 activation assays were performed as described by McLeod
et al., [16]. Brieﬂy, a RalGDS-GST fusion protein bound to Glutha-
thione Sepharose 4B beads was used to pull down the active form
of Rap1 before or after activation with 100 nM CXCL12, which was
detected using an anti-Rap1A/B antibody.
2.5. FRAP of Cx43-GFP transduced WEHI 231 B cells
Cx43-GFP transduced WEHI 231 B cells were incubated on glass
bottom microwell dishes (MatTek, Ashland, MA) that were coated
with 10 lg/ml ﬁbronectin overnight at 37 C, 5% CO2 in complete
media. The following day, ﬂuoresence recovery after photobleach-
ing (FRAP) was assessed using an Olympus FV1000 confocal micro-
scope. A circular ROI was drawn on the cell periphery and
ﬂuorescent intensity was determined every 10 s. The average of
the ﬁrst two intervals was used as the ‘‘pre-bleach’’ intensity. The
ROI was photo-bleached using the tornado setting, and the ﬂuores-
cent intensity at this point was used as the ‘‘bleached’’ intensity.
The ﬂuorescent recovery in this ROI was determined using the
formula ([intensity at a given timepoint]–[bleached intensity])/
([pre-bleach]–[bleached]). Addition of 10 lM cytochalasin D or an
equivalent volume of DMSO was done 10 min prior to FRAP. FRAP
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independent experiments (n = 45 for DMSO and n = 53 for cytocha-
lasin D) at the same timepoint and comparing them using a stu-
dent’s unpaired, two-tailed t test (Microsoft Excel).
2.6. TIRF microscopy
Co-localization of Cx43-GFP and F-actin was accomplished
using total internal reﬂection ﬂuorescence (TIRF) microscopy.
Cx43-GFP transduced WEHI 231 cells were incubated on glass bot-
tom microwell dishes (MatTek) that were coated with 10 lg/ml
ﬁbronectin overnight at 37 C, 5% CO2 in complete media. The fol-
lowing day the cells were ﬁxed with 4% paraformaldehyde and per-
meabilized in PBS containing 0.5% Triton-X 100 for 10 min at room
temperature (RT). The samples were blocked with PBS containing
3% BSA for 30 min at RT then incubated with rhodamine-phalloidin
(1:40 in PBS plus 3% BSA) for 20 min at RT, rinsed three times in
PBS and then left in PBS for imaging. TIRF was accomplished using
a Zeiss spinning disk confocal microscope and the Slidebook ver-
sion 5.0 software.
2.7. Cell motility assays
Glass coverslips (18 mm) were coated with 10 lg/ml bovine
ﬁbronectin (Invitrogen) in 1 PBS for 3 h at RT or overnight at
4 C. The coverslips were washed and coated with ﬂuorescent blue
ﬂuospheres (Invitrogen). B cells were added to the coverslip and
incubated for 18 h at 37 C, 5% CO2 in complete media, after which
the cells were ﬁxed in 4% paraformaldehyde for 20 min. F-actin
was visualized using rhodamine-phalloidin. Individual cell tracks
were observed using a confocal microscope with a 20 objective
and track areas (area of cleared beads) quantiﬁed using ImagePro
software. The track areas from cells transduced with nonsense
(n = 108 cells), sh2 (n = 138) and sh1 + 2 (n = 120) were compared
using a student’s unpaired, two-tailed t test.
2.8. B cell migration
Transwell inserts (5 lm) (Falcon) were coated with 2 g/ml bo-
vine ﬁbronectin (Sigma) for 3 h at RT or overnight at 4 C, washed
with 1 PBS, and placed in a 24 well dish (Falcon) with 600 ll che-
motaxis buffer (RPMI 1640, 10 mM HEPES, 0.5% BSA + 2% FBS). For
migration, WEHI 231 cells were added to the top chamber at
5  102 cells in 100 ll chemotaxis buffer with no chemokine in
the bottom, or with 100 nM CXCL12 in the bottom chamber (for to-
tal number of cells, 5  102 cells were added to a well with no
Transwell chamber). The cells were incubated for 4 h at 37 C, 5%
CO2. The cells from the bottom chamber were then collected, cen-
trifuged at 1500 RPM for 5 min and resuspended in 500 ll FACS
buffer (1PBS with 10% FBS). The percentage of cells migrating
across the Transwell ﬁlter into the bottom chamber was deter-
mined using a FACS LSRII. Cells were counted for 1 min and the dif-
ferent migration conditions were compared to the total number of
cells where percent migration = ([number of cells counted from
migration condition]/[number of cells counted from total
well])  100. The percentage of migrating cells determined for
each condition, from each independent experiment was then com-
pared using a student’s unpaired, two-tailed t test.
2.9. Transendothelial cell migration of WEHI 231 B cells
Transendothelial migration of WEHI 231 cells was determined
using a modiﬁed version of the migration assay previously de-
scribed above. bEND.3 (n = 6 replicates) or SVEC4–10 cells (n = 4
replicates) were grown to a single monolayer on top of a 8.0 lm
Transwell ﬁlter (Falcon) with 10 ng/ml TNF-a (eBioscience,San Diego, CA). The Transwell inserts with the endothelial mono-
layer was added to a 24 well dish with 600 ll of complete DMEM
with or without 50 nM CXCL12 in the bottom chamber. WEHI 231
cells (5  105) resuspended in 100 ll DMEM were added to the top
chamber. The cells were incubated for 24 h at 37 C, 10% CO2. The
percent of migrating cells was determined as described in the
migration assay above.2.10. Immunoﬂuorescence
Non-TIRF immunoﬂuorescence images were taken using stan-
dard protocols on an Olympus FV1000 confocal microscope
[12,21]. Primary and secondary antibody pairswere as follows: Rab-
bit anti-ZO-1: Goat anti-Rabbit conjugated to Alexaﬂuor488; Rabbit
anti-Cx43: Goat anti-Rabbit conjugated to Alexaﬂuor488. The F-ac-
tin cytoskeleton was visualized using Rhodamine phalloidin.
Surface expression of Cx43-EGFP overexpressed by WEHI 231
cells and a-IgM stained endogenous BCR was determined using
standard immunoﬂuorescence procedures [12] without adding
detergent to the buffers so the cells remained un-permeabilized
and only the surface proteins were exposed to the antibodies.
Images were obtained using an Olympus Fluoview 1000 confocal
microscope using a 60 objective as described previously [12,21].2.11. Measuring hemichannel activity, pharmacological blocking
of hemichannels and cell spreading
Hemichannel activity was measured using a modiﬁed proce-
dure recently described by our lab [52] and cell spreading was as-
sayed on anti-BCR coated coverslips as described [12,52]. Brieﬂy,
WEHI 231 cells were incubated 30 min at 37 C with 100 lM car-
benoxolone (CBX, carbenoxolone disodium salt, Sigma). Then,
drug-treated cells were either added directly to anti-BCR coated
coverslips for the spreading assay or washed once in 1 PBS for
the hemichannel assay by dye-uptake. For measuring dye-uptake,
5 million cells were washed once in 1 PBS. Cells were re-sus-
pended in 2 ml of Locke’s buffer (9 g/L NaCl, 0.4 g/L KCl, 0.2 g/L
NaHCO3) with or without divalent cations (0.25 g/L CaCl2). To begin
measuring uptake, 1 ml of Locke’s buffer containing 3 concen-
trated (15 lM) ethidium bromide (Invitrogen, Burlington, ON)
was added for a ﬁnal concentration of 5 lM and images were col-
lected every 30 s for 15 min using a Zeiss Axioplan 2 ﬂuorescence
microscope (MicrOptik, Deursen Netherlands) and Image J analysis
software (NIH, www.rsb.info.nih.gov). For cell spreading WEHI 231
cells were plated on anti-BCR coated coverslips, cells were viewed
using an Olympus FloView confocal microscope, and spreading was
quantiﬁed by measuring the mean contact area (lm2) after 30 min.
Contact area was quantiﬁed using phalloidin stained actin to iden-
tify the cell periphery as previously described [12,52].2.12. Statistics
A comparison of means was assessed using a student’s un-
paired, two-tailed t test and as described in the ﬁgure legends.3. Results
3.1. Cx43 membrane localization is determined by the F-actin
cytoskeleton
The GJ protein Cx43 has been previously linked to the F-actin
cytoskeleton in multiple cell types including astrocytes, tenocytes
and epithelial cells [17–19]. To determine if Cx43 is interacting
with the F-actin cytoskeleton in B-lymphocytes, the colocalization
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technique that focuses on cell surface localized proteins. WEHI
231 B cells transduced with Cx43-GFP were incubated on 10 lg/
ml ﬁbronectin coated glass coverslips for 24 h and subsequently
stained and imaged. WEHI 231 cells are representative of imma-
ture B-lymphocytes and used as a standard tissue culture model
in immunology for the study of BCR-signaling, spreading and
motility since this stage of B cell development is when lympho-
cytes actively migrate [12,16,21,36]. WEHI 231 cells express the
BCR on the cell surface as well as Cx43 (Supplementary Fig. 1).
Cx43-GFP accumulated at the periphery of the spreading cell,
along with F-actin, where there was a strong co-localization be-
tween the two (Fig. 1A). To determine if there was a closer link
between Cx43-GFP and the F-actin cytoskeleton, the mobility of
Cx43-GFP was assessed with and without chemical disruption of
the cytoskeleton using FRAP. WEHI 231 B cells were transduced
with Cx43-GFP and FRAP was assessed at the periphery of cells
incubated on ﬁbronectin-coated coverslips for 24 h. Cx43-GFP at
the periphery showed a maximal mean recovery after 170 s, with
an approximate 50% immobile fraction (Fig. 1B, top). After treat-
ment with 10 lM cytochalasin D, there was a decrease in the
mobility of Cx43-GFP at the periphery of the cell, with an approx-
imate 62% immobile fraction (Fig. 1B, bottom). There was, how-
ever, a change in the organization of Cx43-GFP in the
membrane after disruption of the cytoskeleton. Cx43-GFP redis-
tributed to large, membrane aggregates which were not located
at the periphery of the cell (Fig. 1B, bottom). These results indicate
there is an interaction, either direct or indirect, between the F-ac-
tin cytoskeleton and Cx43-GFP, and the membrane localization of
Cx43 is inﬂuenced by the F-actin cytoskeleton. The results shown
in Fig. 1B are quantiﬁed in Fig. 1C as described in the legend for
Fig. 1.
3.2. Cx43 is important for B cell motility
Lymphocyte motility is an important process in migration and
normal B cell functioning within lymphoid organs [20]. Because
we observed an inﬂuence of the F-actin cytoskeleton on the mem-
brane organization of Cx43, we hypothesized that Cx43 may play a
role in B cell motility. To test this idea, Cx43 protein levels in WEHI
231 B cells were knocked down using shRNA. Transduction of
WEHI 231 cells with Cx43 shRNA construct 2 (speciﬁc for the cyto-
plasmic loop), as well the combination of shRNA constructs 1 (spe-
ciﬁc for the third transmembrane domain) and 2 led to a reduction
in Cx43 protein levels compared to nonsense shRNA transfected
cells (Fig. 2A). These cells were then assayed for their ability to
move on a ﬁbronectin-coated glass coverslip over 18 h. Consistent
with the effect of Cx43 knockdown on the BCR-mediated activation
of the master regulator of B lymphocyte motility, the Rap1 GTPase,
there was a similar decrease in the ability of integrins interacting
with ﬁbronectin to activate Rap1 in Cx43 knockdown WEHI 231
cells (Fig. 2B). To measure the degree of motility, the ﬁbronectin-
coated coverslips were also coated with ﬂuorescent-blue ﬂuo-
spheres. As the cells move along the ﬁbronectin, they push away
the ﬂuospheres leaving a cleared path that can then be measured.
The cleared area represents the combination over the time of incu-
bation in the assay, of forward, backward and sideways move-
ments of the cells. The mean area of the cleared area of WEHI
231 Cx43 nonsense transfected cells was 1470 lm2 whereas WEHI
231 Cx43 shRNA 2 and shRNA 1 + 2 were signiﬁcantly lower at 608
and 730 lm2, respectively (Fig. 2C, quantiﬁed in 2D). This change
in motility was not due to a change in actin polymerization, as
there was no change in FRAP of actin-GFP between the nonsense
shRNA and Cx43 shRNA construct 2 transduced cells (data not
shown). These results indicate that Cx43 is required for efﬁcient
B cell motility.3.3. Cx43 is important for activation of Rap1 and migration in response
to CXCL12
B lymphocytes respond to the chemokine CXCL12 by activating
Rap1 GTPase and migrating along the chemokine gradient [21]. Be-
cause Cx43 plays an important role in B cell motility, we hypothe-
size that it is also required for chemokine-induced migration. The
initiation of signaling through CXCL12 caused an increase in the
molecular weight of Cx43 in WEHI 231 B cells on an SDS–PAGE
gel (Fig. 3A, Left). This change was ﬁrst seen 5 min after addition
of CXCL12, and persisted for 15 min where it began to decline. This
bandshift was likely due to phosphorylation as treatment of the
cell lysate with CIP prior to SDS–PAGE reduced the amount of high-
er molecular weight bands (Fig. 3A, Right). This indicates that Cx43
is likely a downstream target of CXCL12/CXCR4 signaling.
The activation of Rap1 GTPase is critical for chemokine-induced
migration in B lymphocytes [16,21]. To determine if Cx43 plays a
role in CXCL12-induced Rap1 activation, WEHI 231 B cells trans-
duced with nonsense shRNA, Cx43 shRNA construct 2 or a combi-
nation or Cx43 constructs 1 and 2 were activated with 100 nM
CXCL12 and the activation of Rap1 was assessed. Compared to
WEHI 231 cells transfected with nonsense shRNA, cells transfected
with shRNA 1 + 2 constructs and shRNA 2 alone exhibited an
inability to sustain Rap1 activation (Fig. 3B). These results demon-
strate that Cx43 is required for efﬁcient and sustained CXCL12
mediated activation of Rap1.
Binding of the chemokine CXCL12 to its receptor, CXCR4, in-
duces a strong migratory response in WEHI 231 B cells in a Rap1
GTPase-dependent manner [21]. To determine if Cx43 plays a role
in directed B cell migration, WEHI 231 B cells transduced with non-
sense shRNA, Cx43 shRNA construct 2 or a combination of Cx43
shRNA constructs 1 and 2 were assayed for their ability to move
across a ﬁbronectin coated, 5.0 lm transwell ﬁlter towards a
CXCL12 gradient (100 nM). Without the addition of CXCL12 to the
bottom chamber of the transwell, there was negligible migration
in all three transfected cell types after 4 h (Fig. 3C). In the presence
of a CXCL12 gradient there was a twofold decrease in migration
across the Transwell of both of the Cx43 knockdown shRNA
expressingWEHI 231 cells compared to the nonsense shRNA trans-
duced cells after 4 h (Fig. 3C). These results indicate that Cx43 is re-
quired for efﬁcient migration toward a CXCL12 gradient.
3.4. Cx43 is important for transendothelial migration
Transendothelial migration is an important biological process
for B cells migrating from one tissue to another in response to che-
mokines [4]. We have shown that Cx43 is required for B cell motil-
ity and migration towards CXCL12, however it is not known if Cx43
is required for transendothelial migration. In order to assess this, a
modiﬁed Transwell migration assay was used similar to the one
described in [22]. Brieﬂy, an endothelial monolayer was grown to
conﬂuency on a 8.0 lm pore size Transwell ﬁlter and activated
overnight with TNFa. WEHI 231 B cells transduced with nonsense
shRNA, Cx43 shRNA construct 2 or a combination of Cx43 shRNA
constructs 1 and 2 were added to the top chamber and CXCL12
was added to the bottom chamber. After 18 h, the number of WEHI
231 B cells that migrated though the monolayer and ﬁlter and into
the bottom chamber was quantiﬁed. When bEND.3 cells are grown
to a monolayer, they have a long, spindle-shaped morphology,
form tight junctions as determined by ZO-1 staining, and have an
accumulation of Cx43 at perinuclear regions as well as cell:cell
contacts (Fig. 4A). When transendothelial migration across a
bEND.3 monolayer was assessed, there was a twofold decrease in
the number of cells that migrated across the endothelium toward
CXCL12 when Cx43 protein levels were knocked down (Fig. 4B).
To ensure that this was not speciﬁc to bEND.3 endothelial cells,
Fig. 1. Mobility of Cx43-GFP decreases after cytochalasin D disruption of the cytoskeleton. (A) Colocalization of F-actin (red) and Cx43-GFP (green) by TIRF microscopy. WEHI
231 Cx43-GFP cells were incubated on glass coverslips coated with 10 lg/ml of ﬁbronectin for 24 h before imaging (Scale bar: 10 lm). (B) FRAP of Cx43-GFP (green)
transfected WEHI 231 cells incubated on 10 lg/ml of ﬁbronectin for 24 h treated with DMSO alone (top) or cytochalasin D in DMSO (bottom) (Scale bar: 10 lm). Red-dotted
circle in panel B indicates the area photobleached. (C) Quantiﬁcation of ﬂuorescence recovery after photobleaching (pooled data from three independent replicates, n = 45 for
DMSO, n = 53 for cytochalasin D, error bars represent standard error of the mean, ⁄ denotes P < 0.05).
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SVEC4–10, was assessed. These cells, when grown to a monolayer,
have a cuboid morphology, very different in shape from bEND.3
cells, but still show tight junctions as determined by ZO-1 staining,
and a Cx43 distribution similar to that of bEND.3 cells (Fig. 4C).
When migration across these cell layers was assessed, there was
a 2–3-fold decrease when Cx43 expression was knocked down
(Fig. 4D). The overall decrease in the number of WEHI 231 cells
migrating across the SVEC4–10 monolayer compared to the
bEND.3 monolayer was likely due to the cell morphology (a smaller
edge:cell area ratio) and the strength of the tight junctions
(SVEC4–10 cells having a much thicker ZO-1 staining compared
to bEND.3 cells). These results indicate that Cx43 is important for
B cell transendothelial cell migration. Moreover, it possible that
the channel function of Cx43 had little effect since carbenoxelone
treatment, while it inhibited hemichannels in B lymphocytes, had
no effect on the initiation of the cell migration process, cell spread-
ing (Supplementary Fig. 2, [52]).4. Discussion
In this study, we demonstrate that the GJ protein Cx43 plays an
important role in B cell motility, directed migration and transendo-
thelial cell migration (extravasation). Using a ﬂuorescently-tagged
Cx43 we were able to show that the membrane distribution of
Cx43 was inﬂuenced by the F-actin cytoskeleton and that its dis-
ruption resulted in a redistribution of Cx43-GFP from the periphery
of a spreading cell to large membrane aggregates. Using a loss-of-
function approach we showed that Cx43 is required for optimal
motility on ﬁbronectin-coated coverslips, CXCL12-mediated Rap1
activation, and CXCL12-directed migration across a Transwell ﬁl-
ter. We also showed that migration across an endothelial mono-
layer towards a CXCL12 gradient was reduced when Cx43 protein
levels are knocked down. These results indicate that Cx43 is an
important regulator of B cell migration.
B cell migration is a complex process that is regulated by re-
sponses to chemokines, interaction with integrin ligands on other
Fig. 2. Motility of WEHI 231 cells decreases if Cx43 expression is knocked down. (A) Expression of Cx43 in WEHI 231 cells after transduction with nonsense shRNA, Cx43
shRNA construct 2 or Cx43 shRNA constructs 1 + 2 shown by immunoblot. (B) Rap activation assay of WEHI 231 cells as in panel A, during a time course of integrin signaling
after plating on ﬁbronectin. (C) WEHI 231 cells were incubated on 10 lg/ml ﬁbronectin-coated glass coverslips covered in ﬂuospheres (blue). After 18 h, the coverslips were
ﬁxed and the cytoskeleton of the B cells was visualized with rhodamine phalloidin (red). The motility tracks are identiﬁed as the bead-free zones (black). (D) Quantiﬁcation of
the cleared area of beads shown in C (pooled data from three independent experiments, error bars represent standard error of the mean, ⁄ denotes P < 0.05).
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lular signaling cascades [4,22]. In order to address if Cx43 is in-
volved in B cell migration, we divided migration into four basic
parts: reorganization of the F-actin cytoskeleton, the ability to
move, the ability to move towards a chemokine and the ability to
migrate through an endothelial cell monolayer and we asked
whether Cx43 played a role in each process. To address the possi-
bility that Cx43 interacts with the F-actin cytoskeleton in B cells,
we ﬁrst used TIRF microscopy to determine if they were in the
same location. Cx43 has been observed in the same location as F-
actin where it is thought to be interacting with F-actin via interac-
tion with ZO-1 and Drebrin [17,23]. Though B cells do not expressZO-1 or drebrin, there was co-localization of Cx43-GFP and F-actin
in the periphery of B cells spreading on ﬁbronectin. This region of a
spreading/moving cell is important for generating the force re-
quired to drive the membrane forward [24]. When the cytoskele-
ton was disrupted using cytochalasin D, there was a change in
the organization of Cx43-GFP. Cx43-GFP moved from the cell
periphery where there was a large mobile fraction and accumu-
lated in large membrane aggregates with a lower membrane
mobility, indicating that its localization is determined by the F-ac-
tin cytoskeleton. A change in membrane mobility of Cx43 has been
described before in rat mammary tumour cells [25]. Here, Cx43-
GFP was highly mobile in non-junctional areas and decreased in
Fig. 3. Knockdown of Cx43 expression in WEHI 231 B cells using shRNA results in a decrease in CXCL12 mediated signaling, Rap1 activation and migration. (A) CXCL12
signaling leads to phosphorylation of Cx43. Cell lysates were prepared from WEHI 231 B cells after incubation with CXCL12 (100 nM) for the indicated times as described in
the methods. The lysates were separated by SDS–PAGE and Cx43 was detected using an Ab speciﬁc for the cytoplasmic tail. Actin was used as a loading control.
Representative experiment of three similar, independent replicates. (B) Rap1 activation in WEHI 231 Cx43 nonsense, WEHI 231 Cx43 shRNA 1 + 2 and WEHI 231 Cx43 shRNA
2 cells after CXCL12 signaling. Cells were stimulated for the indicated times with CXCL12 (100 nM) and activated Rap (Rap1-GTP) was captured as described in the methods
and in [16]. (C) Transwell migration of WEHI 231 B cells transduced with nonsense shRNA, Cx43 shRNA construct 2 and Cx43 shRNA construct 1 + 2 towards CXCL12. WEHI
231 cells (5  105) were loaded into the top chamber of a Transwell insert with no CXCL12 in the bottom chamber or 100 nM in the bottom chamber. The percent of cells that
migrated to the bottom chamber after 4 h is expressed as the number of cells in the bottom chamber/the total number of cells added (cells added with no Transwell insert).
The data are from four independent experiments, error bars represent standard error of the mean, ⁄ denotes P < 0.05.
S. Machtaler et al. / FEBS Letters 588 (2014) 1249–1258 1255mobility when part of a gap junction plaque. It is possible that in B
lymphocytes, Cx43 is actively recruited to sites of actin polymeri-
zation and uncoupling it from the cytoskeleton leads to self-aggre-
gation and a decrease in membrane mobility.
B cell motility is an important component of B cell immune re-
sponses. The ability of a B cell to move along endothelial cells in
order to ﬁnd sites permissive for transendothelial migration as
well as movement around and within lymphoid tissues is essen-
tial to normal B cell functioning [4,20,26,27]. Here, using a loss-
of-function approach, we observed a decrease in B cell motility
using the simplest conditions possible, by assaying integrin-med-
iated motility of WEHI 231 cells on ﬁbronectin-coated coverslips
without chemokine signals when expression of Cx43 is reduced.
This is consistent with results from other studies on neural migra-
tion [8–10,28,29] with the exception, that in our system, the
change in reduction is independent of GJ cell–cell coupling. Be-
cause the reduced motility of B cells occurs in the absence of a
basement cell layer, it is likely that Cx43 is involved in the signal-
ing pathways leading to cell motility, as opposed to directly facil-
itating motility via passage of small molecules via GJ intercellular
communication.
B cell motility on endothelial cells requires the integration of
outside-in integrin signaling and chemokine-mediated inside-out
signaling resulting in high afﬁnity integrin activation and cytoskel-
etal remodeling [22]. We demonstrated that Cx43 is important for
integrin-mediated B cell motility, however whether it is required
for integrating chemokine signals is not known. To assess whether
Cx43 is required for integrating chemokine signals, we assayed the
response of WEHI 231 cells to the chemokine CXCL12. The chemo-
kine CXCL12 binds to the CXCR4 receptor on B cells where itactivates MAPK, Src family kinases and the GTPase Rap1 resulting
in the activation of integrins and polarization of the cell towards
the signal. When we assayed whether Cx43 was affected by
CXCL12 signaling, we observed that Cx43 became phosphorylated
after stimulation with CXCL12. The cytoplasmic domain of Cx43 is
highly regulated by phosphorylation via c-Src, MAP kinases and
PKC, resulting in changes to the state of the pore and life cycle/
turnover [30–35]. Though it is not known which of these kinases
are required for the CXCL12-mediated phosphorylation of Cx43
in B cells, it is likely that it is involved in the signaling pathway
in a similar manner to the signals downstream of the BCR are in-
volved in B lymphocyte spreading and adhesion [12,36–38].
Activation of the Rap1 GTPase is required for normal B cell
migration and cytoskeletal rearrangements in response to both
chemokine and integrin-mediated signals [16,36,37]. Because we
observed that integrin-mediated motility was reduced after knock-
down of Cx43 and that Cx43 was a target of CXCL12 signaling, we
hypothesized that Cx43 was involved in CXCL12-mediated Rap1
activation. Knockdown of Cx43 expression dramatically reduced
the CXCL12-mediated activation of Rap1, indicating that it is
important for Rap1 activation. Because Cx43 has no intrinsic enzy-
matic activity, it is likely that it is acting as an adaptor/scaffolding
protein, recruiting proteins involved in the regulation of Rap1, such
a role independent of channel function has been the topic of recent
speculation [38,39]. Since activated Rap1 is required for normal B
cell migration towards CXCL12 [16], we assessed whether knock-
down of Cx43 had a similar effect. There was a signiﬁcant decrease
in migration through a ﬁbronectin-coated Transwell insert towards
a CXCL12 gradient, indicating that it is important for normal B cell
migration.
Fig. 4. Knockdown of Cx43 expression in WEHI 231 B cells decreased transendothelial cell migration. (A) Immunoﬂuorescence staining of a bEND.3 monolayer showing ZO-1
(green, top left panels; Cx43 green, top right panels) and the F-actin cytoskeleton (red, bottom panels of each set). Scale bar: 10 lm. (B) Quantiﬁcation of transendothelial cell
migration of WEHI 231 transduced with nonsense shRNA, Cx43 shRNA construct 2 or Cx43 shRNA constructs 1 and 2 through a bEND.3 endothelial cell monolayer as in panel
A. A monolayer of TNFa activated bEND.3 cells was grown on top of the ﬁlter of a Transwell insert and 5  105 WEHI 231 cells were loaded into the top chamber with no
CXCL12 in the bottom chamber or 50 nM in the bottom chamber. The percent of cells that migrated through the monolayer to the bottom chamber after 18 h is expressed as
the number of cells in the bottom chamber/the total number of cells added (cells added with no Transwell insert). Data are pooled from six independent experiments, error
bars represent standard error of the mean, ⁄ denotes P < 0.05. (C) Immunoﬂuorescence staining of a SVEC4–10 monolayer showing ZO-1, Cx43 and the F-actin cytoskeleton as
in panel A. Scale bar: 10 lm. (D) Quantiﬁcation of transendothelial cell migration of WEHI 231 cells as in panel B through a SVEC4–10 endothelial cell monolayer. A
monolayer of TNFa activated SVEC4–10 cells was grown on top of the ﬁlter of a Transwell insert and 5  105 WEHI 231 cells were loaded into the top chamber with no
CXCL12 in the bottom chamber or 50 nM in the bottom chamber. The percent of cells that migrated through the monolayer to the bottom chamber after 18 h is expressed as
the number of cells in the bottom chamber/the total number of cells added (cells added with no Transwell insert). Data are combined from four independent experiments,
error bars represent standard error of the mean, ⁄ denotes P < 0.05).
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in forming channels between cells. Though it has previously been
shown that B cells and endothelial cells form functional gap junc-
tions during the process of transendothelial migration, blockage of
the pore had no effect on it [6]. What has not been investigated is if
Cx43 protein levels are important for this process. Because we ob-
served that Cx43 was required for B cell motility and migration, wehypothesized that it was also important in transendothelial migra-
tion. When we assayed the effect of Cx43 knockdown on B cells
ability to undergo this process, we observed that there was a sig-
niﬁcant decrease in their ability to traverse across the cell layer.
Here, Cx43 is likely acting as a component/adaptor in the signaling
pathways required for transendothelial migration, possibly by reg-
ulating Rap1 GTPase activation. This is consistent with the ﬁnding
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through an endothelial monolayer [21]. When assaying the role
of Cx43 in neuronal migration, Elias et al. observed the Cx43 was
required for cell adhesion and that there was a colocalization of
Cx43 and actin, suggesting that Cx43 was mediating effects though
interaction with the F-actin cytoskeleton [10]. We observed a sim-
ilar co-localization between Cx43 and F-actin where we were able
to show that there was an interaction between the two, and have
previously found that the C-terminal domain of Cx43 is important
for B cell adhesion to endothelial cells [12]. It is possible that Cx43
may be both enhancing adhesion to the endothelium and provide a
platform for the integration of signals required for B cell motility
and migration. These ﬁndings indicate that Cx43 is a novel regula-
tor of B cell migration and suggests that it plays an important role
in biological processes required for normal B cell functioning.
The question that remains is how Cx43 inﬂuences the multi-
step process that results in lymphocyte motility and directed
migration along chemokine gradients, across cell and matrix sur-
faces, and through endothelial cell layers during development in
lymphoid organs and homing to sites of infection [1–4]. Even basic
cellular processes, such as changes in morphology, are now appre-
ciated to involve complex interactions between multiple signaling
networks and the cytoskeleton. The Bakal lab recently identiﬁed,
using a high throughput screen, groups of proteins that regulate
‘switch-like’ transitions between ﬁve discrete cell morphologies
[40]. These observations nicely parallel the changes in cellular
morphology seen in glioma and cardiac neural crest cells when lev-
els of Cx43 are altered [8,44,45]. Similarly, changes in lymphocyte
cell shape lead to alterations in cell polarity, an early step in the re-
sponse to chemokines, and is driven by signaling cascades that re-
sult in rearrangements of the cytoskeleton [41–43]. In support of
this, changes in cell shape and polarity inﬂuenced by Cx43 have
also been shown to be associated with directional migration in
ﬁbroblasts and neural crest cells [44,45]. Currently it is unclear if
these cytoskeletal changes are mediated by the actin cytoskeleton,
by interactions with microtubules, or by the actions of both types
of cytoskeleton [44,45]. In support of this, various analyses have
shown Cx43 interactions with cytoskeletal components [44,50]
and ideas for how this might take place have been reviewed
[38,39,51].
How might Cx43 be mediating these changes in cellular mor-
phology? The Cx43 cytoplasmic tail contains many sites that can
be modiﬁed by phosphorylation, as well as motifs that have the po-
tential of supporting protein–protein interactions [32,33,35,46]. In
particular, there is evidence that the phosphorylation of the Cx43
tail can mediate conformational changes [47] and it is possible that
these changes could contribute to the binding to downstream
effectors [48–51]. Thus, it is attractive to propose that the cytoplas-
mic tail of Cx43 could be the key motif since there is also evidence
of its importance in promoting migration of neurons [9] and in
BCR-mediated cell spreading [12]. What remains to be determined
is how this process works in B-lymphocytes and to identify lym-
phocyte speciﬁc interacting proteins that could link signaling from
the BCR and chemokine receptors to the machinery that regulates
cytoskeletal rearrangements.
Acknowledgements
The authors would like to acknowledge ﬁnancial support from
Grants from CIHR [MOP-111079] to L.M. and to C.C.N., CIHR
[MOP-86486] to L.M., Trainee awards from NSERC and MSFHR to
L.F., and graduate training support from the UBC Dept of Zoology
to S.M. We thank members of the Matsuuchi and Gold labs for in-
put and advice. We also acknowledge support from the LSI Imag-
ing, UBC Bioimaging and UBC Flow Cytometry Facilities.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2014.01.
027.
References
[1] Pillai, S. and Cariappa, A. (2009) The follicular versus marginal zone B
lymphocyte cell fate decision. Nat. Rev. Immunol. 9, 767–777.
[2] Cyster, J.G. (2010) B cell follicles and antigen encounters of the third kind. Nat.
Immunol. 11, 989–996.
[3] Cyster, J.G. (2003) Homing of antibody secreting cells. Immunol. Rev. 194, 48–
60.
[4] Ley, K., Laudanna, C., Cybulsky, M.I. and Nourshargh, S. (2007) Getting to the
site of inﬂammation: the leukocyte adhesion cascade updated. Nat. Rev.
Immunol. 7, 678–689.
[5] Laird, D.W. (2006) Life cycle of connexins in health and disease. Biochem. J.
394, 527–543.
[6] Oviedo-Orta, E., Errington, R.J. and Evans, W.H. (2002) Gap junction
intercellular communication during lymphocyte transendothelial migration.
Cell Biol. Int. 26, 253–263.
[7] Bermudez-Fajardo, A., Yliharsila, M., Evans, W.H., Newby, A.C. and Oviedo-
Orta, E. (2007) CD4+ T lymphocyte subsets express connexin43 and establish
gap junction channel communication with macrophages in vitro. J. Leukoc.
Biol. 82, 608–612.
[8] Bates, D.C., Sin, W.C., Aftab, Q. and Naus, C.C. (2007) Connexin43 enhances
glioma invasion by a mechanism involving the carboxy terminus. Glia 55,
1554–1564.
[9] Cina, C., Maass, K., Theis, M., Willecke, K., Bechberger, J.F. and Naus, C.C. (2009)
Involvement of the cytoplasmic C-terminal domain of connexin43 in neuronal
migration. J. Neurosci. 29, 2009–2021.
[10] Elias, L.A.B., Wang, D.D. and Kriegstein, A.R. (2007) Gap junction adhesion is
necessary for radial migration in the neocortex. Nature 448, 901–908.
[11] Simpson, K.J., Selfors, L.M., Bui, J., Reynolds, A., Leake, D., Khvorova, A. and
Brugge, J.S. (2008) Identiﬁcation of genes that regulate epithelial cell
migration using an siRNA screening approach. Nat. Cell Biol. 10, 1027–
1038.
[12] Machtaler, S., Dang-Lawson, M., Choi, K., Jang, C., Naus, C.C. and Matsuuchi, L.
(2011) The gap junction protein Cx43 regulates B-lymphocyte spreading and
adhesion. J. Cell Sci. 124, 2611–2621.
[13] Mao, A.J., Bechberger, J.F., Lidington, D., Galipeau, J., Laird, D.W. and Naus, C.C.
(2000) Neuronal differentiation and growth control of Neuro-2a cells after
retroviral gene delivery of connexin43. J. Biol. Chem. 275, 34407–34414.
[14] Shao, Q., Wang, H., McLachlan, E., Veitch, G.I.L. and Laird, D.W. (2005) Down-
regulation of Cx43 by retroviral delivery of small interfering RNA promotes an
aggressive breast cancer cell phenotype. Cancer Res. 65, 2705–2711.
[15] Krebs, D.L., Yang, Y., Dang, M., Haussmann, J. and Gold, M.R. (1999) Rapid and
efﬁcient retrovirus-mediated gene transfer into B cell lines. Methods Cell Sci.
21, 57–68.
[16] McLeod, S.J., Li, A.H.Y., Lee, R.L., Burgess, A.E. and Gold, M.R. (2002) The Rap
GTPases regulate B cell migration toward the chemokine stromal cell-derived
factor-1 (CXCL12): potential role for Rap2 in promoting B cell migration. J.
Immunol. 169, 1365–1371.
[17] Butkevich, E., Hülsmann, S., Wenzel, D., Shirao, T., Duden, R. and Majoul, I.
(2004) Drebrin is a novel connexin43 binding partner that links gap junctions
to the submembrane cytoskeleton. Curr. Biol. 14, 650–658.
[18] Wall, M.E., Otey, C., Qi, J. and Banes, A.J. (2007) Connexin43 is localized with
actin in tenocytes. Cell Motil. Cytoskel. 64, 121–130.
[19] Vitale, M.L., Akpovi, C.D. and Pelletier, R.M. (2009) Cortactin/tyrosine-
phosphorylated cortactin interaction with connexin43 in mouse
seminiferous tubules. Microsc. Res. Tech. 72, 856–867.
[20] Cahalan, M.D. and Parker, I. (2008) Choreography of cell motility and
interaction dynamics imaged by two-photon microscopy in lymphoid
organs. Annu. Rev. Immunol. 26, 585–626.
[21] Lin, K.B.L., Tan, P., Freeman, S.A., Lam, M., McNagny, K.M. and Gold, M.R. (2009)
The Rap GTPases regulate the migration, invasiveness and in vivo
dissemination of B-cell lymphomas. Oncogene 29, 608–615.
[22] Shulman, Z., Shinder, V., Klein, E., Grabovsky, V., Yeger, O., Geron, E.,
Montresor, A., Bolomini-Vittori, M., Feigelson, S.W., Kirchhausen, T.,
Laudanna, C., Shakhar, G. and Alon, R. (2009) Lymphocyte crawling and
transendothelial migration require chemokine triggering of high-afﬁnity LFA-
1 integrin. Immunity 30, 384–396.
[23] Giepmans, B.N.G. and Moolenaar, W.H. (1998) The gap junction protein
connexin43 interacts with the second PDZ domain of the zona occludens-1
protein. Curr. Biol. 8, 931–934.
[24] Giannone, G., Dubin-Thaler, B.J., Rossier, O., Cai, Y., Chaga, O., Jiang, G., Beaver,
W., Döbereiner, H.-G., Freund, Y., Borisy, G. and Sheetz, M.P. (2007)
Lamellipodial actin mechanically links myosin activity with adhesion-site
formation. Cell 128, 561–575.
[25] Simek, J., Churko, J., Shao, Q. and Laird, D.W. (2009) Cx43 has distinct mobility
within plasma-membrane domains, indicative of progressive formation of
gap-junction plaques. J. Cell Sci. 122, 554–562.
1258 S. Machtaler et al. / FEBS Letters 588 (2014) 1249–1258[26] Miller, M.J., Wei, S.H., Parker, I. and Cahalan, M.D. (2002) Two-photon imaging
of lymphocyte motility and antigen response in intact lymph node. Science
296, 1869–1873.
[27] Allen, C.D.C., Okada, T., Tang, H.L. and Cyster, J.G. (2007) Imaging of germinal
center selection events during afﬁnity maturation. Science 315, 528–531.
[28] Elias, L.A.B., Turmaine, M., Parnavelas, J.G. and Kriegstein, A.R. (2010)
Connexin43 mediates the tangential to radial migratory switch in ventrally
derived cortical interneurons. J. Neurosci. 30, 7072–7077.
[29] Cina, C., Bechberger, J.F., Ozog, M.A. and Naus, C.C. (2007) Expression of
connexins in embryonic mouse neocortical development. J. Comp. Neurol.
504, 298–313.
[30] Warn-Cramer, B.J., Lampe, P.D., Kurata, W.E., Kanemitsu, M.Y., Loo, L.W.M.,
Eckhart, W. and Lau, A.F. (1996) Characterization of the mitogen-activated
protein kinase phosphorylation sites on the connexin43 gap junction protein.
J. Biol. Chem. 271, 3779–3786.
[31] Sáez, J.C., Nairn, A.C., Czernik, A.J., Fishman, G.I., Spray, D.C. and Hertzberg, E.L.
(1997) Phosphorylation of connexin43 and the regulation of neonatal rat
cardiac myocyte gap junctions. J. Mol. Cell. Cardiol. 29, 2131–2145.
[32] Lampe, P.D., TenBroek, E.M., Burt, J.M., Kurata, W.E., Johnson, R.G. and Lau, A.F.
(2000) Phosphorylation of connexin43 on serine368 by protein kinase C
regulates gap junctional communication. J. Cell Biol. 149, 1503–1512.
[33] Loo, L.W.M., Berestecky, J.M., Kanemitsu, M.Y. and Lau, A.F. (1995) Pp60 -
mediated phosphorylation of connexin43, a gap junction protein. J. Biol. Chem.
270, 12751–12761.
[34] Solan, J.L. and Lampe, P.D. (2009) Connexin43 phosphorylation: structural
changes and biological effects. Biochem. J. 419, 261–272.
[35] Marquez-Rosado, L., Solan, J.L., Dunn, C.A., Norris, R.P. and Lampe, P.D. (2012)
Connexin43 phosphorylation in brain, cardiac, endothelial and epithelial
tissues. BBA-Biomembranes 1818, 1985–1992.
[36] Lin, K.B.L., Freeman, S.A., Zabetian, S., Brugger, H., Weber, M., Lei, V., Dang-
Lawson, M., Tse, K.W.K., Santamaria, R., Batista, F.D. and Gold, M.R. (2008) The
Rap GTPases regulate B cell morphology, immune-synapse formation, and
signaling by particulate B cell receptor ligands. Immunity 28, 75–87.
[37] Tse, K.W.K., Dang-Lawson, M., Lee, R.L., Vong, D., Bulic, A., Buckbinder, L. and
Gold, M.R. (2009) B cell receptor-induced phosphorylation of Pyk2 and focal
adhesion kinase involves integrins and the Rap GTPases and is required for B
cell spreading. J. Biol. Chem. 284, 22865–22877.
[38] Matsuuchi, L. and Naus, C.C. (2013) Gap junction proteins on the move:
connexins, the cytoskeleton and migration. BBA Biomembranes 1828, 94–108.
[39] Kameritsch, P., Pogoda, K. and Pohl, U. (2012) Channel-independent inﬂuence
of connexin43 on cell migration. BBA-Biomembranes 1818, 1993–2001.[40] Yin, Z., Sadok, A., Sailem, H., McCarthy, A., Xia, X., Li, F., Garcia, M.A., Evans, L.,
Barr, A.R., Perrimon, N., Marshall, C.J., Wong, S.T.C. and Bakal, C. (2013) A
screen for morphological complexity identiﬁes regulators of switch-like
transitions between discrete cell shapes. Nat. Cell Biol. 15, 860–872.
[41] Severinson, E. and Westerberg, L. (2003) Regulation of adhesion and motility
in B lymphocytes. Scand. J. Immunol. 58, 139–144.
[42] Ridley, A.J. (2011) Life at the leading edge. Cell 145, 1012–1022.
[43] Nourshargh, S., Hordijk, P.L. and Sixt, M. (2010) Breaching multiple barriers:
leukocyte motility through venular walls and the interstitium. Nat. Rev. Mol.
Cell Biol. 11, 367–378.
[44] Francis, R., Xu, X., Park, H., Wei, C.-J., Chang, S., Chatterjee, B. and Lo, C.W.
(2011) Connexin43 modulates cell polarity and directional cell migration by
regulating microtubule dynamics. PLoS ONE 6, e26379.
[45] Xu, X., Francis, R., Wei, C.-J., Linask, K.L. and Lo, C.W. (2006) Connexin43-
mediated modulation of polarized cell movement and the directional
migration of cardiac neural crest cells. Development 133, 3629–3639.
[46] D’hondt, C., Iyyathurai, J., Vinken, M., Rogiers, V., Leybaert, L., Himpens, B. and
Bultynck, G. (2013) Regulation of connexin- and pannexin-based channels by
post-translational modiﬁcations. Biol. Cell 105, 373–398.
[47] Grosely, R., Kopanic, J.L., Nabors, S., Kieken, F., Spagnol, G., Al-Mugotir, M.,
Zach, S. and Sorgen, P.L. (2013) Effects of phosphorylation on the structure and
backbone dynamics of the intrinsically disordered connexin43 C-terminal
domain. J. Biol. Chem. 288, 24857–24870.
[48] Butkevich, E., Hulsmann, S., Wenzel, D., Shirao, T., Duden, R. and Majoul, I.
(2004) Drebrin is a novel Cx43 binding partner that links gap junctions to the
submembrane cytoskeleton. Curr. Biol. 14, 650–658.
[49] Squecco, R., Sassoli, C., Nuti, F., Martinesi, M., Chellini, F., Nosi, D., Zecchi-
Orlandini, S., Francini, F., Formiﬁli, L. and Meacci, E. (2006) Sphingosine 1-
phosphate induces myoblast differentiation through Cx43 protein expression:
a role for a gap junction-dependent and -independent function. Mol. Biol. Cell
17, 4896–4910.
[50] Olk, S., Turchinovich, A., Grzendowski, M., Steuhler, K., Meyer, H.E., Zoidl, G.
and Dermietzel, R. (2010) Proteomic analysis of astroglial connexin43
silencing uncovers a cytoskeletal platform involved in process formation
and migration. Glia 58, 494–505.
[51] Olk, S., Zoidl, G. and Dermietzel, R. (2009) Connexins, cell motility and the
cytoskeleton. Cell Motil. Cytoskel. 66, 1000–1016.
[52] L. Falk, M. Dang-Lawson, J.-L.V. Pizarro, F. Pournia, K. Choi, C. Jang, C.C. Naus, L.
Matsuuchi, (2014). Mutations of Cx43 that affect B cell spreading in response
to BCR signaling, Biol. Open (In press), http://dx.doi.org/10.1242/
bio.20147328.
